ELCIA

Aurigene – Accelerating Discovery


Aurigene Discovery Technologies Limited is a discovery stage biotech company established in 2002. Our objective is to be the most respected and valued biotech company in India by delivering a high- quality pipeline of clinical candidates addressing unmet needs in the area of oncology and inflammation. Aurigene has the infrastructure for small molecules as well as peptides and has capabilities right from target validation to IND/Clinical PoC.

We have had several multi-year collaborations with the top 10 Pharma companies and also the mid/small biotech companies across the globe. We have collaborated on over 70 integrated discovery programs and delivered several candidates who are currently at various stages of clinical development.

Aurigene has its internal pipeline and has out-licensed several first-in-class and best-in-class compounds to pharma and biotech companies for global clinical development.

Website: https://www.aurigene.com/

Contact details

Subir Dubey – subir_d@aurigene.com (VP, Business Development)

Veerendra Patil – veerendra_p@aurigene.com (Senior Director, HR)

News and updates

Business Development Designer Services – a Webinar on 7th Aug 2020

Dear members,

Do you want to take your business to the next level?

This is time for a brand new journey to be explored!

(more…)

06-08-2020

Information About TReDS

There are many benefits to MSMSs with TReDS. The platform essentially brings together 3 stakeholders – Buyers (Large / Mid corporate’s, PSU / Govt entities, MNCs, etc), Sellers (MSME Vendors or suppliers of these Buyers), and Financiers (Banks, NBFC Factors).

(more…)

29-07-2020

Webinar on Demystifying Government Support Schemes for MSMEs

ELCIA in association with XIME has organized a session on ‘Demystifying Government Support Schemes for MSMEs’.

(more…)

08-07-2020